在公(gong)(gong)(gong)司(si)(si)(si)股東、董事(shi)會、管理(li)層(ceng)及公(gong)(gong)(gong)司(si)(si)(si)各部室(shi)、各成員單位等(deng)的(de)大力支持和(he)配(pei)合下，英特(te)集團非公(gong)(gong)(gong)開發行股票事(shi)項取得重要進展，2019年3月12日，中(zhong)國(guo)證(zheng)券監督(du)管理(li)委員會發行審(shen)核委員會審(shen)核通過了(le)浙江英特(te)集團股份有限公(gong)(gong)(gong)司(si)(si)(si)非公(gong)(gong)(gong)開發行股票的(de)申請。
本(ben)次公(gong)司非公(gong)開股(gu)(gu)(gu)票方(fang)案為，向戰(zhan)略投資者華潤(run)醫藥商業集團有限公(gong)司發行數量不(bu)超(chao)(chao)過總股(gu)(gu)(gu)本(ben)的20%、約為4100萬股(gu)(gu)(gu)的公(gong)司股(gu)(gu)(gu)票，募集資金(jin)不(bu)超(chao)(chao)過6.5億元，用于(yu)補充流(liu)動資金(jin)。
本次非(fei)公(gong)(gong)(gong)(gong)開(kai)發(fa)(fa)行(xing)(xing)(xing)股(gu)(gu)(gu)(gu)票(piao)工作于2018年(nian)(nian)(nian)(nian)初啟動，經(jing)過(guo)(guo)多(duo)方(fang)研究論證，開(kai)展了(le)多(duo)場與潛在的(de)(de)(de)戰略投資者的(de)(de)(de)路演活動，進(jin)(jin)行(xing)(xing)(xing)了(le)為期大(da)半年(nian)(nian)(nian)(nian)的(de)(de)(de)對(dui)公(gong)(gong)(gong)(gong)司(si)(si)(si)經(jing)營(ying)、發(fa)(fa)展、財務、合規(gui)等全方(fang)位的(de)(de)(de)盡職調查，形成非(fei)公(gong)(gong)(gong)(gong)開(kai)發(fa)(fa)行(xing)(xing)(xing)預(yu)案。2018年(nian)(nian)(nian)(nian)9月25日，公(gong)(gong)(gong)(gong)司(si)(si)(si)八(ba)屆二(er)(er)十(shi)四次董事(shi)會(hui)、八(ba)屆十(shi)六次監(jian)(jian)事(shi)會(hui)審議(yi)通過(guo)(guo)了(le)非(fei)公(gong)(gong)(gong)(gong)開(kai)發(fa)(fa)行(xing)(xing)(xing)股(gu)(gu)(gu)(gu)票(piao)事(shi)宜相(xiang)(xiang)關議(yi)案。2018年(nian)(nian)(nian)(nian)10月22日，非(fei)公(gong)(gong)(gong)(gong)開(kai)發(fa)(fa)行(xing)(xing)(xing)股(gu)(gu)(gu)(gu)票(piao)事(shi)宜獲得(de)浙江省國(guo)資委(wei)批準(zhun)。2018年(nian)(nian)(nian)(nian)11月6日，公(gong)(gong)(gong)(gong)司(si)(si)(si)2018年(nian)(nian)(nian)(nian)第二(er)(er)次臨時(shi)股(gu)(gu)(gu)(gu)東大(da)會(hui)審議(yi)通過(guo)(guo)了(le)非(fei)公(gong)(gong)(gong)(gong)開(kai)發(fa)(fa)行(xing)(xing)(xing)股(gu)(gu)(gu)(gu)票(piao)事(shi)宜相(xiang)(xiang)關議(yi)案。2018年(nian)(nian)(nian)(nian)11月，非(fei)公(gong)(gong)(gong)(gong)開(kai)發(fa)(fa)行(xing)(xing)(xing)股(gu)(gu)(gu)(gu)票(piao)獲得(de)證監(jian)(jian)會(hui)受(shou)理。2019年(nian)(nian)(nian)(nian)1月18日，公(gong)(gong)(gong)(gong)司(si)(si)(si)就(jiu)證監(jian)(jian)會(hui)審查反(fan)饋(kui)意(yi)見進(jin)(jin)行(xing)(xing)(xing)了(le)回(hui)復。2019年(nian)(nian)(nian)(nian)2月26日，公(gong)(gong)(gong)(gong)司(si)(si)(si)就(jiu)證監(jian)(jian)會(hui)發(fa)(fa)審會(hui)告知函進(jin)(jin)行(xing)(xing)(xing)了(le)回(hui)復。2019年(nian)(nian)(nian)(nian)3月12日，證監(jian)(jian)會(hui)審核(he)通過(guo)(guo)了(le)公(gong)(gong)(gong)(gong)司(si)(si)(si)非(fei)公(gong)(gong)(gong)(gong)開(kai)發(fa)(fa)行(xing)(xing)(xing)股(gu)(gu)(gu)(gu)票(piao)的(de)(de)(de)申請(qing)，尚待(dai)取得(de)證監(jian)(jian)會(hui)的(de)(de)(de)書面(mian)核(he)準(zhun)文件。公(gong)(gong)(gong)(gong)司(si)(si)(si)后(hou)續將根據證監(jian)(jian)會(hui)書面(mian)核(he)準(zhun)文件要(yao)求和(he)公(gong)(gong)(gong)(gong)司(si)(si)(si)股(gu)(gu)(gu)(gu)東大(da)會(hui)的(de)(de)(de)授權，推進(jin)(jin)本次非(fei)公(gong)(gong)(gong)(gong)開(kai)發(fa)(fa)行(xing)(xing)(xing)股(gu)(gu)(gu)(gu)票(piao)相(xiang)(xiang)關工作。